Theodore T Wang - Net Worth and Insider Trading

Theodore T Wang Net Worth

The estimated net worth of Theodore T Wang is at least $3,423 dollars as of 2024-05-12. Theodore T Wang is the Director, 10% Owner of Bellerophon Therapeutics Inc and owns about 60,913 shares of Bellerophon Therapeutics Inc (BLPH) stock worth over $3,423. Details can be seen in Theodore T Wang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Theodore T Wang has not made any transactions after 2020-06-08 and currently still holds the listed stock(s).

Transaction Summary of Theodore T Wang

To

Theodore T Wang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Theodore T Wang owns 6 companies in total, including Bellerophon Therapeutics Inc (BLPH) , Ekso Bionics Holdings Inc (EKSO) , and TRACON Pharmaceuticals Inc (TCON) among others .

Click here to see the complete history of Theodore T Wang’s form 4 insider trades.

Insider Ownership Summary of Theodore T Wang

Ticker Comapny Transaction Date Type of Owner
BLPH Bellerophon Therapeutics Inc 2023-06-07 director
EKSO Ekso Bionics Holdings Inc 2018-08-03 director & 10 percent owner
TCON TRACON Pharmaceuticals Inc 2018-04-06 director & 10 percent owner
2017-01-18 10 percent owner
2022-01-28 10 percent owner
2022-12-16 director

Theodore T Wang Latest Holdings Summary

Theodore T Wang currently owns a total of 1 stock. Theodore T Wang owns 60,913 shares of Bellerophon Therapeutics Inc (BLPH) as of June 8, 2020, with a value of $3,423.

Latest Holdings of Theodore T Wang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BLPH Bellerophon Therapeutics Inc 2020-06-08 60,913 0.06 3,423

Holding Weightings of Theodore T Wang


Theodore T Wang Form 4 Trading Tracker

According to the SEC Form 4 filings, Theodore T Wang has made a total of 5 transactions in Bellerophon Therapeutics Inc (BLPH) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in Bellerophon Therapeutics Inc is the acquisition of 7,586 shares on June 8, 2020, which cost Theodore T Wang around $96,873.

Insider Trading History of Theodore T Wang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Theodore T Wang Trading Performance

GuruFocus tracks the stock performance after each of Theodore T Wang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Theodore T Wang is -1.37%. GuruFocus also compares Theodore T Wang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Theodore T Wang within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Theodore T Wang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Theodore T Wang

Average Return

Average return per transaction

Outperforming Transactions

4 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 1.16
Relative Return to S&P 500(%) -1.65

Theodore T Wang Ownership Network

Ownership Network List of Theodore T Wang

No Data

Ownership Network Relation of Theodore T Wang


Theodore T Wang Owned Company Details

What does Bellerophon Therapeutics Inc do?

Who are the key executives at Bellerophon Therapeutics Inc?

Theodore T Wang is the director of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .

Bellerophon Therapeutics Inc (BLPH) Insider Trades Summary

Over the past 18 months, Theodore T Wang made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .

In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.

Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bellerophon Therapeutics Inc Insider Transactions

No Available Data

Theodore T Wang Mailing Address

Above is the net worth, insider trading, and ownership report for Theodore T Wang. You might contact Theodore T Wang via mailing address: C/o Puissance Capital Management Lp, 950 Third Avenue, 25th Floor, New York Ny 10022.

Discussions on Theodore T Wang

No discussions yet.